One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
The global burden of oral diseases: stronger data for stronger action
Ultra-long-acting biological therapy for chronic rhinosinusitis with nasal polyps
Towards definitive evidence about anticoagulation for atrial fibrillation after intracranial haemorrhage
Rebuilding trust and equity in Syria's health system: a governance-driven transition
A call for health R&D prioritisation and governance mechanisms in Africa
Canada and the EU united for global health, but challenges remain
Natural or artificial menstrual cycle for frozen embryo transfer
TRiP(cast) score and thrombosis risk for lower limb immobilisation
TRiP(cast) score and thrombosis risk for lower limb immobilisation
TRiP(cast) score and thrombosis risk for lower limb immobilisation
TRiP(cast) score and thrombosis risk for lower limb immobilisation – Authors' reply
Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial
